rs58667649

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_021098.3(CACNA1H):​c.5675G>A​(p.Arg1892His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000194 in 1,552,680 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1892L) has been classified as Benign.

Frequency

Genomes: 𝑓 0.00016 ( 0 hom., cov: 34)
Exomes 𝑓: 0.00020 ( 3 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

3
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.683

Publications

8 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.02485764).
BP6
Variant 16-1218439-G-A is Benign according to our data. Variant chr16-1218439-G-A is described in ClinVar as Benign. ClinVar VariationId is 1169274.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000158 (24/152308) while in subpopulation SAS AF = 0.00145 (7/4824). AF 95% confidence interval is 0.00068. There are 0 homozygotes in GnomAd4. There are 16 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High AC in GnomAd4 at 24 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_021098.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1H
NM_021098.3
MANE Select
c.5675G>Ap.Arg1892His
missense
Exon 33 of 35NP_066921.2
CACNA1H
NM_001005407.2
c.5657G>Ap.Arg1886His
missense
Exon 32 of 34NP_001005407.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1H
ENST00000348261.11
TSL:1 MANE Select
c.5675G>Ap.Arg1892His
missense
Exon 33 of 35ENSP00000334198.7
CACNA1H
ENST00000569107.6
TSL:1
c.5690G>Ap.Arg1897His
missense
Exon 32 of 34ENSP00000454990.2
CACNA1H
ENST00000711493.1
c.5693G>Ap.Arg1898His
missense
Exon 32 of 34ENSP00000518778.1

Frequencies

GnomAD3 genomes
AF:
0.000158
AC:
24
AN:
152190
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000341
AC:
54
AN:
158130
AF XY:
0.000393
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.0000804
Gnomad ASJ exome
AF:
0.000117
Gnomad EAS exome
AF:
0.000182
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000112
Gnomad OTH exome
AF:
0.00134
GnomAD4 exome
AF:
0.000198
AC:
277
AN:
1400372
Hom.:
3
Cov.:
33
AF XY:
0.000250
AC XY:
173
AN XY:
690952
show subpopulations
African (AFR)
AF:
0.0000631
AC:
2
AN:
31698
American (AMR)
AF:
0.0000557
AC:
2
AN:
35938
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25190
East Asian (EAS)
AF:
0.0000837
AC:
3
AN:
35852
South Asian (SAS)
AF:
0.00174
AC:
138
AN:
79348
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
47854
Middle Eastern (MID)
AF:
0.00265
AC:
15
AN:
5666
European-Non Finnish (NFE)
AF:
0.0000861
AC:
93
AN:
1080634
Other (OTH)
AF:
0.000412
AC:
24
AN:
58192
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
21
42
62
83
104
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000158
AC:
24
AN:
152308
Hom.:
0
Cov.:
34
AF XY:
0.000215
AC XY:
16
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.0000481
AC:
2
AN:
41556
American (AMR)
AF:
0.000261
AC:
4
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00145
AC:
7
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000147
AC:
10
AN:
68024
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000102
Hom.:
0
Bravo
AF:
0.000106
ExAC
AF:
0.000196
AC:
21

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Jul 12, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.089
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.24
CADD
Benign
7.0
DANN
Uncertain
1.0
DEOGEN2
Benign
0.11
T
Eigen
Benign
-0.87
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.059
N
LIST_S2
Benign
0.61
T
M_CAP
Uncertain
0.23
D
MetaRNN
Benign
0.025
T
MetaSVM
Uncertain
0.18
D
MutationAssessor
Benign
0.34
N
PhyloP100
-0.68
PrimateAI
Benign
0.42
T
PROVEAN
Benign
-0.32
N
REVEL
Benign
0.29
Sift
Benign
0.12
T
Sift4G
Benign
0.11
T
Polyphen
0.70
P
Vest4
0.12
MVP
0.69
ClinPred
0.010
T
GERP RS
-0.61
Varity_R
0.053
gMVP
0.29
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs58667649; hg19: chr16-1268439; API